Assessment of immune modulation of β-adrenergic pathways in human dilated cardiomyopathy: Influence of methodologic factors
- 30 April 1992
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 123 (4) , 967-970
- https://doi.org/10.1016/0002-8703(92)90704-y
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effect of antireceptor antibodies in dilated cardiomyopathy on the cycling of cardiac beta receptorsAmerican Heart Journal, 1991
- Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy.Journal of Clinical Investigation, 1990
- Influence of anti-beta-receptor antibodies on cardiac adenylate cyclase in patients with idiopathic dilated cardiomyopathyAmerican Heart Journal, 1990
- Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathyJournal of the American College of Cardiology, 1990
- Anti-beta-receptor antibodies in human dilated cardiomyopathy and correlation with HLA-DR antigensThe American Journal of Cardiology, 1990
- Effect of cardiac transplantation on anti-beta-receptor antibodies in idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1989
- Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy.Circulation Research, 1989
- Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathyJournal of Molecular and Cellular Cardiology, 1985
- Rapid recovery of cardiac beta-adrenergic receptors after isoproterenol-induced "down"-regulation.Circulation Research, 1984
- A highly sensitive adenylate cyclase assayAnalytical Biochemistry, 1974